Skip to main content
Top
Published in: Rheumatology International 4/2009

01-02-2009 | Original Article

Association of (−1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms)

Authors: I. Ömer Barlas, Melek Sezgin, M. Emin Erdal, Günsah Sahin, Handan Camdeviren Ankarali, Zühal Mert Altintas, Ebru Türkmen

Published in: Rheumatology International | Issue 4/2009

Login to get access

Abstract

The aim of this study was to investigate whether functional polymorphisms in the promoter of matrix metalloproteinase-1 (MMP-1), MMP-2 and MMP-9 genes were associated with susceptibility to knee osteoarthritis in the Turkish population. The MMP-1 −1,607 1G/2G (rs1799750), MMP-2 −1,306 C/T (rs243865), and MMP-9 −1,562 C/T (rs3918242) polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism assay in 157 patients diagnosed with knee osteoarthritis based on the criteria of American College of Rheumatology and in 84 controls in Mersin, Turkey. Genotype distributions and allele frequencies of MMP-1, MMP-2, and MMP-9 gene polymorphisms were compared between the patients and controls. There were significant differences between the groups regarding the genotype distribution of MMP-1 polymorphism ( = 0.001). The frequencies of 1G/1G and 1G/2G genotypes were significantly higher in the knee osteoarthritis than in the controls (P = 0.002, and P =  0.006, respectively). In addition, 1G allele frequency of MMP-1 gene was higher in the patients than in the control group (P = 0.0001). The genotype distributions and allele frequencies of MMP-2 and MMP-9 gene polymorphisms did not differ between the osteoarthritis and the control groups (P > 0.05). These findings suggest that the −1,607 1G/2G polymorphism in the MMP-1 gene may contribute to susceptibility to knee osteoarthritis in the Turkish population.
Literature
1.
go back to reference Solomon L (2001) Clinical features of osteoarthritis. In: Ruddy S, Harris ED, Sledge CB (eds) Kelley’s textbook of rheumatology. WB Saunders, Philadelphia, pp 1409–1418 Solomon L (2001) Clinical features of osteoarthritis. In: Ruddy S, Harris ED, Sledge CB (eds) Kelley’s textbook of rheumatology. WB Saunders, Philadelphia, pp 1409–1418
2.
go back to reference Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR (1995) Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96:2859–2869. doi:10.1172/JCI118357 PubMedCrossRef Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR (1995) Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96:2859–2869. doi:10.​1172/​JCI118357 PubMedCrossRef
7.
go back to reference Fernandes JC, Martel-Pelletier J, Lascau-Coman V et al (1998) Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 25:1585–1594PubMed Fernandes JC, Martel-Pelletier J, Lascau-Coman V et al (1998) Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 25:1585–1594PubMed
8.
go back to reference Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777–2789. doi :10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-HPubMedCrossRef Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777–2789. doi :10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-HPubMedCrossRef
9.
10.
go back to reference Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44:585–594. doi :10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-CPubMedCrossRef Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44:585–594. doi :10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-CPubMedCrossRef
12.
go back to reference Rutter JL, Mitchell TI, Butticè G et al (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5325PubMed Rutter JL, Mitchell TI, Butticè G et al (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5325PubMed
14.
go back to reference Zhang B, Ye S, Herrmann SM et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–1794PubMed Zhang B, Ye S, Herrmann SM et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–1794PubMed
15.
go back to reference Kanamori Y, Matsushima M, Minaguchi T et al (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMed Kanamori Y, Matsushima M, Minaguchi T et al (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMed
16.
go back to reference Nishioka Y, Kobayashi K, Sagae S et al (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612–615PubMed Nishioka Y, Kobayashi K, Sagae S et al (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612–615PubMed
17.
go back to reference Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H (1999) Genetic analysis of MMP3, MMP9 and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568. doi:10.1006/bbrc.1999.1721 PubMedCrossRef Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H (1999) Genetic analysis of MMP3, MMP9 and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568. doi:10.​1006/​bbrc.​1999.​1721 PubMedCrossRef
19.
go back to reference Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMed Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMed
20.
go back to reference Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558. doi:10.1074/jbc.M010242200 PubMedCrossRef Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558. doi:10.​1074/​jbc.​M010242200 PubMedCrossRef
22.
24.
go back to reference Zhang XM, Miao XP, Xiong P et al (2004) Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng 23:1233–1237PubMed Zhang XM, Miao XP, Xiong P et al (2004) Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng 23:1233–1237PubMed
26.
go back to reference Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic, California, pp 300–356 Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic, California, pp 300–356
27.
go back to reference Ghilardi G, Biondi ML, Mangoni J et al (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7:2344–2346PubMed Ghilardi G, Biondi ML, Mangoni J et al (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7:2344–2346PubMed
28.
go back to reference Kanamori Y, Matsushima M, Minaguchi T et al (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMed Kanamori Y, Matsushima M, Minaguchi T et al (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMed
29.
go back to reference Zhu Y, Spitz MR, Lei L, Mills GB, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825–7829PubMed Zhu Y, Spitz MR, Lei L, Mills GB, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825–7829PubMed
30.
go back to reference Ninomiya S, Niimi T, Shimizu S et al (2004) Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21:19–24PubMed Ninomiya S, Niimi T, Shimizu S et al (2004) Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21:19–24PubMed
32.
go back to reference Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209–214. doi:10.1016/j.jhep.2004.04.024 PubMedCrossRef Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209–214. doi:10.​1016/​j.​jhep.​2004.​04.​024 PubMedCrossRef
33.
go back to reference Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558 Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558
36.
go back to reference Yu C, Pan K, Xing D et al (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430–6433PubMed Yu C, Pan K, Xing D et al (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430–6433PubMed
37.
39.
go back to reference Sugimoto M, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T (2006) Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig 13:523–529PubMed Sugimoto M, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T (2006) Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig 13:523–529PubMed
Metadata
Title
Association of (−1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms)
Authors
I. Ömer Barlas
Melek Sezgin
M. Emin Erdal
Günsah Sahin
Handan Camdeviren Ankarali
Zühal Mert Altintas
Ebru Türkmen
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2009
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0705-6

Other articles of this Issue 4/2009

Rheumatology International 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.